Greater Seattle Area
Advancing cell and gene therapies for patients with amazing teams and cutting edge science.
Helping daring gene and cell therapy companies and institutions achieve their R&D and CMC milestones.
Head of Viral Vector Research. Lead a research team working on IND enabling and IND approved cell and gene therapies. Development of viral vectors for use as in vivo gene delivery therapies, overcoming intrinsic barriers to cell therapy gene delivery.
Head of Viral Vector Research. Building a team developing cell and gene therapies. Cancer Immunotherapy, Viral Vectors, Molecular Biology, Genetic Engineering, cell control.
Head of Gene Engineering & Delivery. Leading a research team developing CAR-T cell therapies, viral and non-viral vectors, molecular engineering, suicide switches. Part of the team that developed FDA approved CAR-T cell therapy, Breyanzi as well as other IND-approved cell therapies. Cancer Immunotherapy, Viral Vectors, Molecular Biology, Genetic Engineering, cell control.
- Developed the ZVex (LV305) platform from pre-clinical to clinical stage. - Expertise in viral vectors, particularly lentiviral vector design, technology, manufacturing, and CMC. - Cancer Immunotherapy, particularly dendritic cell biology. - Virus and host interactions, particularly in considerations of viral vectors designed to successfully transduce host targets. - IND enabling preclinical studies. - IND, RAC, IB and other regulatory filings.
PhD thesis on virus host interactions in the lab of Michael Emerman.